01.03.2018
- The US Food and Drug Administration (FDA) has approved AstraZeneca and MedImmune’s immunotherapy Imfinzi (durvalumab) to treat patients with a certain form of lung cancer. Imfinzi...
07.12.2017
- The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...
04.12.2017
- AstraZeneca and GI Therapeutics, a US clinical-stage oncology company, are collaborating to test a new combination therapy for lung cancer. The parties will evaluate AstraZeneca’s...
21.11.2017
- European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...
20.11.2017
- US healthcare giant Johnson & Johnson (J&J) has won another victory in a string of lawsuits claiming its talc-based baby powder causes cancer. The jury in the state of California...
09.11.2017
- The US Food and Drug Administration has approved a new drug developed by Eli Lilly to treat a common type of breast cancer. Verzenio is recommended both for women and men with HR...
23.10.2017
- In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac. Lilly will make an equity investment of...
27.09.2017
- Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...
